2024 Bristol meyers squibb stock - BMY Earnings Date and Information. Bristol-Myers Squibb last released its quarterly earnings data on October 26th, 2023. The biopharmaceutical company reported $2.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.76 by $0.24. The company earned $10.97 billion during the quarter, compared to …

 
Get Bristol-Myers Squibb Co. (BMY) share price, real-time stock quotes, historical charts and financial information. Start Investing in Bristol-Myers Squibb .... Bristol meyers squibb stock

See Bristol-Myers Squibb Company stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Bristol-Myers Squibb Company. BMY NYSE. BMY NYSE. BMY NYSE. BMY NYSE. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials …Get Bristol-Myers Squibb Co. (BMY) share price, real-time stock quotes, historical charts and financial information. Start Investing in Bristol-Myers Squibb ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Bristol Myers Squibb stock recently dropped to a multiyear low, and the pharmaceutical company’s lead independent director bought shares on the open market for the first time in years ...BMY - Bristol-Myers Squibb Co. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)Bristol Myers Squibb missed analysts' Q1 estimates for both the top and bottom lines. Revenue rose 3% year over year to $11.1 billion, a little short of the consensus Wall Street estimate of $11. ...Bristol Myers Squibb’s fundamentals have been robust over the last 2 years. Its revenue grew 25.8% from $20.8 billion in 2017 to $26.1 billion in 2019. The company also managed to expand its Net ...BMY Stock Information - Bristol Myers Squibb United States Investors Stock Information Stock Information View our detailed stock quote, explore our stock chart and look up our historical stock quote. Quotes delayed at least 20 minutes. Market data provided by Ticker Tech. Terms & Conditions. Powered and implemented by Ticker Tech. Bristol Myers Squibb (BMY) Quote Overview ... It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.Nov 24, 2020 · Bristol Myers Squibb is attractively valued no matter how you look at the stock. Its shares trade at only a little over eight times expected earnings -- well below most of its peers. An easy decision See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.New York-based Bristol-Myers Squibb (BMY-0.41%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income.Jul 18, 2023 · By 1943, Squibb operated the largest penicillin production plant in the world in New Brunswick, New Jersey. After the war and into the 1960s, both Squibb and Bristol-Myers expanded their production and research of antibiotics. They merged in 1989, creating a powerhouse pharmaceutical company that was the second-largest in the world at the time. 3.64B. -4.79%. Get the latest Bristol-Myers Squibb Co (BMY) real-time quote, historical performance, charts, and other financial information to help you make more informed …Bristol Myers Squibb has been striving hard to improve lives by providing better healthcare solutions since the early 1800s. Learn more about our company's history. ... Chairman and CEO Giovanni Caforio rings the New York Stock Exchange’s Closing Bell in celebration of the company milestone. 2017Target values for the price of one Bristol-Myers share for Aug 2024. The weighted average target price per Bristol-Myers share in Aug 2024 is: 55.70. In Aug, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 5.570% volatility is expected. Pessimistic target level: 53.50. Optimistic target level: 56.65.9 окт. 2023 г. ... ... Bristol-Myers Squibb's cancer drug portfolio. Alnylam Pharmaceuticals (ALNY) shares move lower ahead of Monday's closing bell after ...Based on short-term price targets offered by 17 analysts, the average price target for Bristol Myers Squibb comes to $62.29. The forecasts range from a low of $50.00 to a high of $85.00. The ...Bristol Myers Squibb stock (NYSE: BMY) was down 6% in yesterday’s trade, while it’s down around 10% in a month. The recent fall can be attributed to the AXIOMATIC MATIC-SSP study of Milvexian ...To learn more about or to purchase our stock online through EQ Shareowner Services, please visit https://www.shareowneronline.com. To request an enrollment package by phone: 1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the ... Bristol-Myers Squibb's stock is down 40% despite a market increase of 20%. Read here why we think BMY may be undervalued.BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ... Stock Price Forecast. The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00. The ...See the latest Bristol-Myers Squibb Co stock price (BMY:XNYS), related news, valuation, dividends and more to help you make your investing decisions.9 окт. 2023 г. ... ... Bristol-Myers Squibb's cancer drug portfolio. Alnylam Pharmaceuticals (ALNY) shares move lower ahead of Monday's closing bell after ...Bristol Myers Squibb's disappointing medium-term guidance on its new product portfolio justified the valuation de-rating as investors assessed the increased execution risks. Accordingly, BMS ...New York-based Bristol-Myers Squibb (BMY 1.46%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income.Bristol-Myers Squibb Company has appointed EQ Shareowner Services as Administrator for the plan. The plan is not sponsored or administered by Bristol-Myers Squibb Company. Form 10-K For a free copy of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, contact: Corporate Secretary* Bristol-Myers Squibb CompanyGoing by our Bristol Myers Squibb Valuation of $79 per share, based on $7.52 expected adjusted EPS and around 10x P/E multiple for 2021, there is an upside potential of 45% from its current levels ...A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.9 окт. 2023 г. ... ... Bristol-Myers Squibb's cancer drug portfolio. Alnylam Pharmaceuticals (ALNY) shares move lower ahead of Monday's closing bell after ...Bristol-Myers Squibb Co’s stock is NA in 2023, NA in the previous five trading days and down 37.41% in the past year. Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.5. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% net profit margin. Year-over-year quarterly sales growth most recently ... Bristol-Myers Squibb Share Price Live Today:Get the Live stock price of BMY Inc., and quote, performance, latest news to help you with stock trading and ...Bristol-Myers Squibb's revenue was $11,406 million in Q4 2022, showing mixed results compared to previous quarters, and there are many explanations for this, which will be discussed in the article ...Find the latest analyst research for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.26 окт. 2022 г. ... Bristol Myers Squibb CEO Dr. Giovanni Caforio joins CNBC's 'Squawk on the Street' to discuss the company's third-quarter earnings report.The Motley Fool owns shares of and recommends Berkshire Hathaway (B shares) and Bristol Myers Squibb and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B ...Find real-time BMY - Bristol-Myers Squibb Co stock quotes, company profile, news and forecasts from CNN Business. ... Bristol-Myers Squibb Co (NYSE:BMY) 50.11. Delayed Data. As of Dec 01To learn more about or to purchase our stock online through EQ Shareowner Services, please visit https://www.shareowneronline.com. To request an enrollment package by phone: 1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the ... Bristol Myers Squibb has been striving hard to improve lives by providing better healthcare solutions since the early 1800s. Learn more about our company's history. ... Chairman and CEO Giovanni Caforio rings the New York Stock Exchange’s Closing Bell in celebration of the company milestone. 2017Nov 10, 2023 · We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ... 1-800-721-5072. (toll free U.S. only) As of 2019, Bristol Myers Squibb and Celgene have merged. If you or someone you know have possibly experienced a side effect or have a product complaint while taking a legacy Celgene product, please contact us. …Discover historical prices for BMY stock on Yahoo Finance. View daily, weekly or monthly format back to when Bristol-Myers Squibb Company stock was issued.forbes.com - November 10 at 8:14 AM. Bristol-Myers Squibb (NYSE:BMY) shareholders have endured a 34% loss from investing in the stock a year ago. finance.yahoo.com - November 10 at 8:14 AM. Bristol Myers Squibb to Participate in the 2023 Jefferies London Healthcare Conference. finance.yahoo.com - November 9 at 4:34 …Dec 01, 2023, 1:56 pm EST. Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Continue reading this article with a …Many Bristol-Myers Squibb Company insiders ditched their stock over the past year, which may be of interest to the company's shareholders.When evaluating insider transactions, knowing whether ...Bristol-Myers Squibb insiders own about US$63m worth of shares. That equates to 0.06% of the company. This level of insider ownership is good but just short of …Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price. 20 нояб. 2023 г. ... Bristol Myers Squibb(NYSE: BMY), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as ...Bristol-Myers Squibb Co Follow Share $48.90 After Hours: $49.00 (0.20%) +0.100 Closed: Nov 20, 6:58:27 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc. $29.98 PFE0.20% AbbVie Inc... The stock price of Bristol Myers Squibb (NYSE: BMY) has seen a 4% drop over the last five trading sessions led by a recent sell-off in large-cap pharmaceutical stocks over the past week or so ...Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors despite daily gains 12/01/23-3:43AM EST MarketWatch Bristol Myers Squibb new CEO buys company sharesBristol Myers Squibb EPS for the quarter ending September 30, 2023 was $0.93, a 24% increase year-over-year. Bristol Myers Squibb EPS for the twelve months ending September 30, 2023 was $3.94, a 28.34% increase year-over-year. Bristol Myers Squibb 2022 annual EPS was $2.95, a 5.45% decline from 2021. Bristol Myers Squibb 2021 …20 нояб. 2023 г. ... Bristol Myers Squibb(NYSE: BMY), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as ...The 52 analysts offering price forecasts for Bristol-Myers Squibb have a median target of 70.35, with a high estimate of 95.00 and a low estimate of 50.00. The ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. Medical - Biomedical and Genetics. $99.500B. $46.159B. Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, …Dec 1, 2023 · Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Boerner paid $150,000 on Nov. 28 for 3,071 Bristol Myers shares, an average price of $48. ... According to the issued ratings of 18 analysts in the last year, the consensus rating for Bristol-Myers Squibb stock is Hold based on the current 1 sell rating, 13 hold ratings and 4 buy ratings for BMY. The average twelve-month price prediction for Bristol-Myers Squibb is $63.59 with a high price target of $85.00 and a low price target of $50. ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.1. Bristol Myers Squibb’s Revenue Growth Is Stronger. Merck’s sales have jumped from $39.8 billion in 2016 to $54.1 billion over the last twelve months, while Bristol Myers Squibb’s revenues ...1-800-721-5072. (toll free U.S. only) Report side effects or product quality complaints about legacy celgene products (ABRAXANE ® , IDHIFA ® , INREBIC ®, ISTODAX ®, POMALYST ®, REBLOZYL ®, REVLIMID ®, THALOMID ®, VIDAZA ®) Learn more >. Below is a list of our company's marketed products. Any linked documents and websites are intended ...Bristol-Myers Squibb Company Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...Bristol-Myers Squibb Company Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to Pfizer stock (NYSE: PFE), given its better growth prospects and comparatively lower valuation of 3.0x ...Nov 10, 2023 · We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ... The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [1] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.Key statistics. Bristol-Myers Squibb Co (BMY:NYQ) set a new 52-week low during today's trading session when it reached 48.25. Over this period, the share price is down -39.13%. Data delayed at least 15 minutes, as of Nov 30 2023 16:26 GMT. Latest Bristol-Myers Squibb Co (BMY:NYQ) share price with interactive charts, historical prices ...VIENNA STOCK EXCHANGE - BRISTOL-MYERS SQUIBB CO stocks (ISIN: US1101221083) - price data, chart, performance & dividend for BRISTOL-MYERS SQUIBB CO.Dec 01, 2023, 3:00 am EST. Bristol Myers Squibb stock recently dropped to a multiyear low, and the pharmaceutical company’s lead independent director bought shares on the open market for the ...Are you looking to invest in biopharmaceutical stocks? Find historical stock quotes and get information including opening price, stock performance and more.Bristol-Myers Squibb Company stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions.Bayer Stock Plunges, Bristol Myers Squibb Falls After Negative Drug-Trial Result The week is off to an ugly start for some pharmaceutical investors. Bayer said it is halting a trial for asundexian, an experimental cardiovascular drug, due …Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Stock Price Forecast. The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00. The ...Bristol Myers Squibb ( BMY 1.46%), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as much as 4% in early action Monday. BMS' stock has ...Bristol Myers' lung cancer drug candidate could be just months away from U.S. Food and Drug Administration approval. Last month, Bristol Myers Squibb ( BMY -0.20%) shared that its locally advanced ...1,862.64 +53.62(+2.96%) Crude Oil 74.38 -1.58(-2.08%) Gold 2,091.70 +34.50(+1.68%) Advertisement Bristol-Myers Squibb Company (BMY) NYSE - NYSE Delayed Price. Currency in USD Follow 2W 10W 9M...Bristol-Myers Squibb Company Common Stock (BMY) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Bristol-Myers Squibb Insiders Are Selling The Stock. Over the last three months, we've seen significant insider selling at Bristol-Myers Squibb. In total, insiders sold US$1.1m worth of shares in ...Key statistics. Bristol-Myers Squibb Co (BMY:NYQ) set a new 52-week low during today's trading session when it reached 48.25. Over this period, the share price is down -39.13%. Data delayed at least 15 minutes, as of Nov 30 2023 16:26 GMT. Latest Bristol-Myers Squibb Co (BMY:NYQ) share price with interactive charts, historical prices ...Bristol Myers Squibb cut its guidance for the sales of new drugs from $10-$13 bln in 2025 to $10+ bln in 2026. The company now lists 9 medications as part of its new product portfolio. They ...Bristol meyers squibb stock

Dec 1, 2023 · The latest Bristol-Myers Squibb stock prices, stock quotes, news, and BMY history to help you invest and trade smarter. . Bristol meyers squibb stock

bristol meyers squibb stock

The Wall Street Analyst consensus on Bristol Myers Squibb ( NYSE: BMY) is overwhelmingly bullish. Out of 21 analyst ratings, nearly half (10) are very bullish, 4 are bullish, 7 are neutral, and 0 ...Interactive Chart for Bristol-Myers Squibb Company (BMY), analyze all the data with a huge range of indicators.We believe that Bristol Myers Squibb stock (NYSE: BMY) is a good buying opportunity at the present time. BMY stock trades near $63 currently and it is, in fact, down 6% from its pre-Covid high of ...Share Price. Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically ...1-800-721-5072. (toll free U.S. only) Report side effects or product quality complaints about legacy celgene products (ABRAXANE ® , IDHIFA ® , INREBIC ®, ISTODAX ®, POMALYST ®, REBLOZYL ®, REVLIMID ®, THALOMID ®, VIDAZA ®) Learn more >. Below is a list of our company's marketed products. Any linked documents and websites are intended ...New York-based Bristol-Myers Squibb (BMY-0.41%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income.Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year.New York-based Bristol-Myers Squibb (BMY 1.46%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income.View Bristol Myers Squibb Company BMY investment & stock information. Get the latest Bristol Myers Squibb Company BMY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Bristol-Myers Squibb Insiders Are Selling The Stock. Over the last three months, we've seen significant insider selling at Bristol-Myers Squibb. In total, insiders sold US$1.1m worth of shares in ...At Bristol Myers Squibb, the work you do—often in support of emerging therapeutic areas that require new methods of thinking and working—will help people prevail over serious diseases. And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. This isn’t easy work, but it is uniquely ...Dec 01, 2023, 1:56 pm EST. Bristol Myers Squibb CEO Chris Boerner just bought a large block of the drug company’s slumping shares. Continue reading this article with a …BMY - Bristol-Myers Squibb Co. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)View today's Bristol-Myers Squibb Co DRC stock price and latest BMY news and analysis. Create real-time notifications to follow any changes in the live ...Zacks Equity Research. Bristol Myers Squibb (BMY) closed at $57.85 in the latest trading session, marking a -0.33% move from the prior day. This move lagged the S&P 500's daily gain of 0.01% ...Nov 20, 2023 · Currently, Bristol-Myers Squibb Co’s price-earnings ratio is 12.9. Bristol-Myers Squibb Co’s trailing 12-month revenue is $44.9 billion with a 18.4% profit margin. Year-over-year quarterly sales growth most recently was -2.2%. Analysts expect adjusted earnings to reach $7.550 per share for the current fiscal year. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in ...The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New …Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of …Healthcare giant Bristol Myers Squibb (BMY-0.20%) is a prime example of Wall Street's sudden renewed interest in these long-forgotten core tenants of stock picking. Image source: Getty Images.Interactive Chart for Bristol-Myers Squibb Company (BMY), analyze all the data with a huge range of indicators.BMY - Bristol-Myers Squibb Co. Stock - Stock Price, Institutional Ownership, Shareholders (NYSE)We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ...Combining Bristol-Myers Squibb's Debt And Its 29% Return On Equity. Bristol-Myers Squibb clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.30.About Bristol-Myers Squibb Stock (NYSE:BMY) The Bristol-Myers Squibb Company is a leading global biopharmaceutical company with a long and impressive history of innovating and developing medicines that improve the lives of patients around the world. Founded in 1887 when William McLaren Bristol and John Ripley Myers purchased the Clinton ... To this point, Bristol Myers Squibb at $60 a share is trading at just eight times this year's average analyst EPS forecast of $7.48. And Bristol Myers Squibb's 3.2% dividend yield is moderately ...NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2022, which reflect robust growth of the in-line and new product portfolios, driven by strong commercial execution and continued progress of the company's pipeline. “2022 was a successful year for our company, one of …BMY) stock’s latest price update. The stock of Bristol-Myers Squibb Co. (NYSE: BMY) has increased by 1.46 when compared to last closing price of 49.38.Despite this, the company has seen a gain of 0.68% in its stock price over the last five trading days. Zacks Investment Research reported 2023-11-29 that The FDA has undertaken an investigation ...20 нояб. 2023 г. ... Bristol Myers Squibb(NYSE: BMY), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as ...Bristol-Myers Squibb is forecast to grow earnings and revenue by 11.4% and 0.1% per annum respectively. EPS is expected to grow by 11.9% per annum. Return on equity is forecast to be 46.2% in 3 years.Detailed statistics for Bristol-Myers Squibb Company (BMY) stock, including valuation metrics, financial numbers, share information and more. Skip to main content. Log In Free Trial. Home. Stocks. ... Bristol-Myers Squibb Company (BMY) NYSE: BMY · IEX Real-Time Price · USD. Add to Watchlist 50.10 +0.72 (1.46%) At close: Dec 1, …NEW YORK--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) today reports results for the third quarter of 2021, which reflect solid sales, strong commercial execution and continued progress of the company’s pipeline. “Our strong results reflect increased adoption of our new product portfolio and continued demand growth …Are you looking to invest in biopharmaceutical stocks? Find historical stock quotes and get information including opening price, stock performance and more.Bristol Myers Squibb Co. historical stock charts and prices, analyst ratings, financials, and today’s real-time BMY stock price.Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.At Bristol Myers Squibb, the work you do—often in support of emerging therapeutic areas that require new methods of thinking and working—will help people prevail over serious diseases. And while our work transforms the lives of patients, it also transforms the lives and careers of those who do it. This isn’t easy work, but it is uniquely ...Healthcare giant Bristol Myers Squibb (BMY-0.20%) is a prime example of Wall Street's sudden renewed interest in these long-forgotten core tenants of stock picking. Image source: Getty Images.We estimate Bristol Myers Squibb’s Valuation to be $77 per share, reflecting over 45% upside from its current levels of $52. Our forecast is based on a 10x P/E multiple for BMY and expected ...Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com. The Bristol Myers Squibb 52-week high stock price is 81.42, which is 62.5% above the current share price. The Bristol Myers Squibb 52-week low stock price is 48.25, which is 3.7% below the current share price. The average Bristol Myers Squibb stock price for the last 52 weeks is 64.65. For more information on how our historical price data is ...Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com . Discover the stock split history of Bristol Myers Squibb and other stock-related corporate actions taken in the past.To learn more about or to purchase our stock online through EQ Shareowner Services, please visit https://www.shareowneronline.com. To request an enrollment package by …View today's Bristol-Myers Squibb Co DRC stock price and latest BMY news and analysis. Create real-time notifications to follow any changes in the live ...My levels to trade BMY Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $70.91 with a high forecast of $85.00 and a low forecast of $56.00. Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. Find out the direct holders, institutional holders and mutual fund holders for Bristol-Myers Squibb Company (BMY). To learn more about or to purchase our stock online through EQ Shareowner Services, please visit https://www.shareowneronline.com. To request an enrollment package by phone: 1-855-598-5485 toll-free within the U.S. 1-651-450-4064 from outside the U.S. A telecommunications relay service should be used by the hearing impaired when calling the ...Bristol-Myers Squibb Co Follow Share $48.90 After Hours: $49.00 (0.20%) +0.100 Closed: Nov 20, 6:58:27 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc. $29.98 PFE0.20% AbbVie Inc... Nov 29, 2023 · The Bristol-Myers Squibb stock price fell by -0.409% on the last day (Wednesday, 29th Nov 2023) from $48.92 to $48.72. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 1.40% from a day low at $48.67 to a day high of $49.35. The price has fallen in 6 of the last 10 days and is down by -3.56% for this period. Bristol Myers Squibb Co. Watch list NEW Set a price target alert After Hours Last Updated: Dec 1, 2023 7:59 p.m. EST Delayed quote $ 50.17 0.07 0.14% After Hours Volume: 403.99K Advanced Charting... The next Bristol-Myers Squibb Co. dividend is expected to go ex in 1 month and to be paid in 2 months. The previous Bristol-Myers Squibb Co. dividend was 57c and it went ex 2 months ago and it was paid 1 month ago. There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 1.4.26 окт. 2023 г. ... Bristol Myers raised the low end of its full-year earnings guide by 15 cents a share, and now expects to earn an adjusted $7.50 to $7.65 per ...The company reported net earnings attributable to Bristol Myers Squibb of $2.3 billion, or GAAP EPS of $1.07, in the first quarter, compared to $1.3 billion, or $0.59 per share, for the same period a year ago. In addition to the items discussed above, the higher GAAP EPS in the first quarter of 2023 was due to lower equity investments losses ...Bristol Myers Squibb (BMY) closed at $67.24 in the latest trading session, marking a -0.4% move from the prior day. This move was narrower than the S&P 500's daily loss of 1.65%.My levels to trade BMY Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. The average price target is $70.91 with a high forecast of $85.00 and a low forecast of $56.00. Based on 12 Wall Street analysts offering 12 month price targets for Bristol-Myers Squibb in the last 3 months. Track Bristol-Myers Squibb Co. (BMY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsForward-looking statements contained on this website should be evaluated together with the many uncertainties that affect Bristol Myers Squibb's business, particularly those identified in the cautionary factors discussion in the company’s most recent annual report on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.Pharmaceutical giant Bristol Myers Squibb's (BMY 1.46%) purchase of Celgene turned it into a dominant player in oncology and hematology, and this year, the company has aggressively strengthened ...Bristol-Myers Squibb Company has appointed EQ Shareowner Services as Administrator for the plan. The plan is not sponsored or administered by Bristol-Myers Squibb Company. Form 10-K For a free copy of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, contact: Corporate Secretary* Bristol-Myers Squibb CompanyBristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in ...Bristol Myers Squibb's disappointing medium-term guidance on its new product portfolio justified the valuation de-rating as investors assessed the increased …Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. A high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 26 окт. 2022 г. ... Bristol Myers Squibb CEO Dr. Giovanni Caforio joins CNBC's 'Squawk on the Street' to discuss the company's third-quarter earnings report.Medical - Biomedical and Genetics. $99.500B. $46.159B. Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, …. Best short stocks